THORACOSCOPIC LEFT ATRIAL APPENDAGE AMPUTATION CAN BE AN ALTERNATIVE TO ENDOVASCULAR OCCLUSION
Zakir Z. Khalimov,
Sergey E. Mamchur,
Irina N. Mamchur,
Nikita S. Bokhan,
Kirill A. Kozyrin,
Anna V. Ivanova https://doi.org/10.17802/2306-1278-2024-13-1-116-121
Abstract
Highlights
We present a clinical case of a patient with atrial fibrillation and a high bleeding risk according to HAS-BLED bleeding risk score who underwent thoracoscopic left atrial appendage (LAA) occluder implantation due to lack of endovascular access. Thoracoscopic amputation of LAA also can be performed in cases where an endovascular access cannot be achieved due to occlusion of the inferior vena cava or thrombosis of LAA. However, it is necessary to monitor the condition of the stump when conducting thoracoscopic amputation of LAA, and stop anticoagulation therapy only in case of non-embologenic stump.
Abstract
Atrial fibrillation is the most common rhythm disorder that can be conservatively treated using antiarrhythmic therapy, and anticoagulants can be used to prevent thromboembolic complications. However, prolonged use of anticoagulants is complicated by the risk of bleeding. Left atrial appendage (LAA) occluder implantation is an alternative way of preventing of thromboembolic and hemorrhagic complications. The article presents a clinical case of thoracoscopic LAA amputation after unsuccessful endovascular LAA occluder implantation in the patient with the inferior vena cava occlusion.
About the Authors
Zakir Z. Khalimov
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
MD, Medical Resident, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Sergey E. Mamchur
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
MD, PhD, Head of the Laboratory of Arrhythmology and Pacing, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Irina N. Mamchur
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
MD, PhD, Physician at the Department of Functional and Ultrasonic Diagnostics, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Nikita S. Bokhan
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
MD, Endovascular Diagnostics and Treatment Specialist, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
Kirill A. Kozyrin
Federal State Budgetary Institution “A.V. Vishnevsky National Medical Research Center for Surgery” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD, PhD, Cardiovascular Surgeon, Federal State Budgetary Institution “A.V. Vishnevsky National Medical Research Center for Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Anna V. Ivanova
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Russian Federation
Russian Federation
MD, Physician at the Department of Functional and Ultrasonic Diagnostics, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation
References
1. Mamchur S.E., Gorbunova E.V., Scherbinina D.A., Romanova M.P. Prevention of thromboembolic complications after atrial fibrillation cat heter ablation using dabigatran. Complex Issues of Cardiovascular Diseases. 2014;(1):59-66. doi:10.17802/2306-1278-2014-1-59-66. (In Russian)
2. Jame S., Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020;106 (1):10-17. doi: 10.1136/heartjnl-2019-314898.
3. Osadchiy A.M., Agarkov M.V., Vlasenko S.V., Stovpyuk O.F., Pavlova N.E., Mamaeva O.P., Miller J.V., Kamenev A.V., Gureev S.V., Lebedeva S.V., Shcherbak S.G., Lebedev D.S. Left atrial appendage occluder implantation for prevention of systemic embolism. First experience in the North-West region. Translational Medicine. 2016;3(3):59–66. doi:10.18705/2311-4495-2016-3-3-59-66. (In. Russian)
4. Altiok E., Marx N. Oral Anticoagulation. Dtsch Arztebl Int. 2018 Nov 16;115(46):776-783. doi: 10.3238/arztebl.2018.0776.
5. Guo Y., Lip G.Y., Apostolakis S. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants. Hosp. Pract. (1995). 2013 Feb; 41(1):71-78. doi: 10.3810/hp.2013.02.1012.
6. Meier B., Blaauw Y., Khattab A.A., Lewalter T., Sievert H., Tondo C., Glikson M. EHRA/ EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention. 2014;10:1109-1125. doi: 10.4244/EIJY14M09_18.
7. Holmes D.R. Atrial fibrillation and stroke management: present and future. Semin Neurol. 2010;30(5):528-536. doi: 10.1055/s-0030-1268861.
8. Sedaghat A., Schrickel J-W., Andrié R., Schueler R., Nickenig G., Hammerstingl C. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device. JACC Clin Electrophysiol. 2017;3(1):71-75. doi: 10.1016/j.jacep.2016.05.006.
9. Harris R.D. The etiology of inferior vena caval obstruction and compression. CRC Crit Rev Clin Radiol Nucl Med. 1976;8(1):57-86.
10. Saha S., Krishnan K., Kavinsky C.J., Jolly N., Parekh K., Kalra D. Pardon the Interruption: An Interrupted Inferior Vena Cava Discovered During Attempted Implantation of a Left Atrial Appendage Occlusion Device. JACC Cardiovasc Interv. 2017;11(17):155-157. doi: 10.1016/j.jcin.2017.05.062.
Supplementary files
Review
For citations:
Khalimov Z.Z., Mamchur S.E., Mamchur I.N., Bokhan N.S., Kozyrin K.A., Ivanova A.V. THORACOSCOPIC LEFT ATRIAL APPENDAGE AMPUTATION CAN BE AN ALTERNATIVE TO ENDOVASCULAR OCCLUSION. Complex Issues of Cardiovascular Diseases. 2024;13(1):116-121. (In Russ.) https://doi.org/10.17802/2306-1278-2024-13-1-116-121
Views:
427
